Vanegas-Arroyave, Nora http://orcid.org/0000-0002-5073-4024
Caroff, Stanley N.
Citrome, Leslie
Crasta, Jovita
McIntyre, Roger S.
Meyer, Jonathan M.
Patel, Amita
Smith, J. Michael
Farahmand, Khody
Manahan, Rachel
Lundt, Leslie
Cicero, Samantha A.
Funding for this research was provided by:
Neurocrine Biosciences
Article History
Accepted: 27 February 2024
First Online: 19 March 2024
Declarations
:
: The expert roundtable referenced in this article was supported by Neurocrine Biosciences, Inc. (San Diego, CA). Writing and editorial assistance from Prescott Medical Communications Group (Chicago, IL) and open access funding were also provided by Neurocrine Biosciences.
: N.V.A. has received consulting honoraria from Neurocrine Biosciences and research support from the National Institutes of Health and the Parkinson’s Disease Foundation. S.N.C. has served as a consultant to Neurocrine Biosciences, Teva Pharmaceuticals, Osmotica Pharmaceuticals, and Dispersol Technologies. S.N.C. has received separate research grants from Neurocrine Biosciences, Osmotica Pharmaceuticals, and Eagle Pharmaceuticals. L.C. has received consulting fees from: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Delpor, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, Inmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Luye, Lyndra, MapLight, Marvin, Medavante-ProPhase, Merck, Mitsubishi-Tanabe Pharma, Neumora, Neurocrine, Neurelis, Noema, Novartis, Noven, Otsuka, Ovid, Praxis, Recordati, Relmada, Reviva, Sage, Sumitomo/Sunovion, Supernus, Teva, University of Arizona, Vanda, Wells Fargo, and one-off ad hoc consulting for individuals/entities conducting marketing, commercial, or scientific scoping research; is a speaker for: AbbVie/Allergan, Acadia, Alkermes, Angelini, Axsome, BioXcel, Eisai, Idorsia, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Recordati, Sage, Sunovion, Takeda, Teva, and CME activities organized by medical education companies such as Medscape, NACCME, NEI, Vindico, and universities and professional organizations/societies; owns stocks (small number of shares of common stock) in: Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer purchased > 10 years ago, stock options: Reviva; and receives royalties/publishing income from: Taylor & Francis (Editor-in-Chief, Current Medical Research and Opinion, 2022-date), Wiley (Editor-in-Chief, International Journal of Clinical Practice, through end 2019), UpToDate (reviewer), Springer Healthcare (book), and Elsevier (Topic Editor, Psychiatry, Clinical Therapeutics) J.C. has been a consultant or advisor to Neurocrine Biosciences, Sunovion, Takeda, AstraZeneca, Otsuka, Janssen, Actavis (now AbbVie), Lundbeck, and Alkermes. R.S.M. has received research support from the Global Alliance for Chronic Diseases, Canadian Institutes of Health Research, National Natural Science Foundation of China-Mental Health Team, and the Milken Institute, and speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine Biosciences, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris Pharma, Sanofi, Eisai, Intra-Cellular Therapies, NewBridge Pharmaceuticals, Viatris, Abbvie, and Atai Life Sciences. R.S.M. is the CEO of Braxia Scientific Corp. J.M.M. has served as a speaker or advisor for Alkermes, AbbVie, Axsome, BioXcel, Cerevel, Intra-Cellular Therapies, Karuna, Neurocrine Biosciences, Noven Pharmaceuticals, Otsuka America, Inc., Relmada, Sunovion, and Teva Pharmaceuticals. A.P. has received consultant or speaker fees from Neurocrine Biosciences, Avanir Pharmaceuticals, Acadia Pharmaceuticals, Otsuka, Allergan (now AbbVie), Teva Pharmaceuticals, AstraZeneca, and Takeda. J.M.S. has received consulting fees from Neurocrine Biosciences. K.F., R.M., and S.A.C. are full-time employees of Neurocrine Biosciences, Inc. L.L. is a former full-time employee of Neurocrine Biosciences.
: N.V.A. and S.N.C. were involved in the conception and planning of the expert roundtable discussion. N.V.A., S.N.C., L.C., J.C., R.S.M., J.M.M., A.P., and J.M.S. participated in the expert roundtable featured in this article. All authors contributed to the development of the manuscript and provided critical reviews of multiple drafts. All authors approved the final draft for submission.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.